Supplementary material
Published: 15 December 2025| Version 1 | DOI: 10.17632/hzdvdzds2p.1
Contributors:
Eric Simpson, Marie Louise Anna Schuttelaar, Sonja Molin, Margarida Goncalo, Jart Oosterhaven, Xing-Hua Gao, Sumeet Uppal, Dimittri Delevry, Andrew Korotzer, Ana RossiDescription
Supplement to the article "Dupilumab treatment improves health-related quality of life in patients with moderate-to-severe atopic dermatitis primarily affecting the hands (atopic hand eczema): results from a randomized placebo-controlled trial"
Files
Categories
Atopic Dermatitis, Quality of Life Study
Funders
- Regeneron (United States)United States